Filing Details

Accession Number:
0000899243-18-030964
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-13 20:41:26
Reporting Period:
2018-12-12
Accepted Time:
2018-12-13 20:41:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1552451 Myokardia Inc MYOK () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1413822 Anastasios Gianakakos C/O Myokardia, Inc.
333 Allerton Avenue
South San Francisco CA 94080
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-12 3,000 $55.68 72,087 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 85,973 Indirect By Reporting Person's Trust 2
Common Stock 500,000 Indirect By Reporting Person's Trust 3
Common Stock 12,200 Indirect By Trust 1
Common Stock 12,200 Indirect By Trust 2
Common Stock 12,200 Indirect By Trust 3
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person
  2. Represents the weighted average sale price of the shares sold ranging from $55.33 to $55.98 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price